Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

4.5K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.5K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

2.7K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.7K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

4.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT.

Bone marrow transplantation·2026
Same author

Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA).

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Metabolic syndrome and cardiovascular disease after haematopoietic cell transplantation (HCT) in adults: an EBMT cross-sectional non-interventional study.

Bone marrow transplantation·2021
Same author

Impact of patient: donor HLA disparity on reduced-intensity-conditioned allogeneic stem cell transplants from HLA mismatched unrelated donors for AML: from the ALWP of the EBMT.

Bone marrow transplantation·2020
Same author

Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria).

Bone marrow transplantation·2020
Same author

Postremission Consolidation by Autologous Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia in First Complete Remission (CR) and Negative Implications for Subsequent Allogeneic HCT in Second CR: A Study by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2019

Related Experiment Video

Updated: Apr 16, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

15.1K

G-CSF-primed BM for allogeneic SCT: revisited.

I Pessach1, I Resnick2, A Shimoni1

  • 1Division of Hematology, Bone Marrow Transplantation & CBB, Chaim Sheba Medical Center, Tel Hashomer, Israel.

Bone Marrow Transplantation
|March 3, 2015
PubMed
Summary

G-CSF-primed bone marrow (GBM) transplants offer faster engraftment and immune reconstitution similar to G-CSF-mobilized peripheral blood stem cell (GPB) grafts. GBM may reduce graft-versus-host disease (GVHD) risk, making it an attractive option for allogeneic stem cell transplants.

More Related Videos

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.5K
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

14.2K

Related Experiment Videos

Last Updated: Apr 16, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

15.1K
Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

8.5K
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

14.2K

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • G-CSF-mobilized peripheral blood stem cell (GPB) grafts offer faster engraftment and immune reconstitution compared to steady-state bone marrow (SBM) grafts.
  • However, GPB grafts do not improve transplant-related mortality (TRM), disease-free survival (DFS), or overall survival (OS) compared to SBM.
  • Graft-versus-host disease (GVHD) incidence is higher with GPB compared to SBM grafts.

Purpose of the Study:

  • To evaluate the efficacy and safety of G-CSF-primed bone marrow (GBM) grafts in allogeneic stem cell transplantation (SCT).
  • To compare GBM grafts with GPB and SBM grafts regarding engraftment, immune reconstitution, and GVHD incidence.
  • To determine if GBM grafts can offer the advantages of GPB without the increased risk of GVHD.

Main Methods:

  • Comparison of cell dose and progenitor cell content between GPB, SBM, and GBM grafts.
  • Analysis of engraftment kinetics and immunological reconstitution following transplantation with different graft types.
  • Assessment of TRM, DFS, OS, and GVHD incidence in patients receiving SCT with GPB, SBM, or GBM grafts.

Main Results:

  • GBM grafts stimulate hematopoietic stem cell (HSC) proliferation, leading to a higher cell dose and faster engraftment compared to SBM.
  • GBM grafts may induce tolerance and modulate donor hematopoiesis and immunity, potentially reducing GVHD incidence.
  • Engraftment and immunological reconstitution with GBM are comparable to GPB, but with a potentially lower GVHD risk.

Conclusions:

  • GBM transplants may provide faster engraftment and immunological reconstitution, similar to GPB grafts.
  • GBM grafts might offer the benefits of GPB transplantation without the associated increased risk of GVHD.
  • GBM represents a potentially attractive graft source for allogeneic SCTs, balancing efficacy and safety.